Asfotase alfa |
رقم الكتالوجGC70297 |
Asfotase alfa (ENB-0040) هو بروتين سكري موجه وراثيا للعظام.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1174277-80-5
Sample solution is provided at 25 µL, 10mM.
Asfotase alfa (ENB-0040) is a bone-targeted genetically engineered glycoprotein. Asfotase alfa increases the survival rate, bone mineralization and bone length and prevents mineralization defects of the feet, rib cage, lower limbs, jaw bones in Akp2−/− knockout mice. Asfotase alfa can be used for the research of perinatal, infantile, and juvenile-onset hypophosphatasia (HPP).
Asfotase alfa (0.5-8.2 mg/kg; s.c. once daily for 43 days) shows dose-response relationships that strongly support the pharmacological efficacy for HPP[1].
References:
[1]. Yadav MC, et al. Dose response of bone-targeted enzyme replacement for murine hypophosphatasia. Bone. 2011 Aug;49(2):250-6.
Review for Asfotase alfa
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Asfotase alfa
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *